Holen Sie sich die Stockscreener-App
5.115
0.64%
-0.0327
Schlusskurs vom Vortag:
$5.1477
Offen:
$5.216
24-Stunden-Volumen:
8,007
Relative Volume:
0.03
Marktkapitalisierung:
$13.69M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-58.52M
KGV:
-2.4474
EPS:
-2.09
Netto-Cashflow:
$-45.03M
1W Leistung:
+5.03%
1M Leistung:
+7.46%
6M Leistung:
+575.43%
1J Leistung:
+227.88%
1-Tages-Spanne:
$5.0109
$5.216
1-Wochen-Bereich:
$4.75
$5.23
52-Wochen-Spanne:
$0.224
$6.42
Nextcure Inc Stock (NXTC) Company Profile
Firmenname
Nextcure Inc
Sektor
Branche
Telefon
240-399-4900
Adresse
9000 VIRGINIA MANOR ROAD, SUITE 200, BELTSVILLE, MD
Vergleichen Sie NXTC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NXTC
Nextcure Inc
|
5.115 | 13.78M | 0 | -58.52M | -45.03M | -2.09 |
|
VRTX
Vertex Pharmaceuticals Inc
|
392.79 | 100.07B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.41 | 59.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
448.91 | 58.03B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
653.83 | 39.93B | 3.06B | 1.28B | -614.78M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
321.36 | 36.82B | 3.81B | -644.79M | -669.77M | -6.24 |
Nextcure Inc Stock (NXTC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-11-04 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
| 2022-03-01 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2021-03-05 | Hochstufung | Truist | Hold → Buy |
| 2021-01-15 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2020-07-16 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2020-07-13 | Herabstufung | ROTH Capital | Buy → Neutral |
| 2020-07-13 | Herabstufung | SunTrust | Buy → Hold |
| 2020-06-01 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2020-06-01 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2020-05-26 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2020-03-24 | Eingeleitet | The Benchmark Company | Buy |
| 2020-03-02 | Eingeleitet | ROTH Capital | Buy |
| 2020-01-13 | Eingeleitet | SunTrust | Buy |
| 2019-12-05 | Eingeleitet | Needham | Buy |
| 2019-11-26 | Eingeleitet | BTIG Research | Buy |
| 2019-07-09 | Eingeleitet | BofA/Merrill | Buy |
| 2019-06-03 | Eingeleitet | Morgan Stanley | Overweight |
| 2019-06-03 | Eingeleitet | Piper Jaffray | Overweight |
Alle ansehen
Nextcure Inc Aktie (NXTC) Neueste Nachrichten
Can you recover from losses in NextCure Inc.July 2025 PostEarnings & Technical Confirmation Alerts - Newser
Real time alert setup for NextCure Inc. performance2025 Winners & Losers & Fast Entry High Yield Tips - Newser
Will NextCure Inc. stock recover after recent drop2025 Volume Leaders & Daily Price Action Insights - Newser
Visualizing NextCure Inc. stock with heatmapsQuarterly Market Review & Fast Gaining Stock Reports - Newser
Why NextCure Inc. stock attracts strong analyst attentionJuly 2025 Short Interest & Low Risk High Reward Ideas - Newser
Does NextCure Inc. qualify in momentum factor screeningEarnings Overview Summary & Weekly Watchlist for Consistent Profits - Newser
How NextCure Inc. stock performs during market volatility2025 Market Overview & Fast Moving Trade Plans - Newser
NextCure Inc. Earnings Report Breakdown: What Investors Should KnowJobs Report & Weekly Consistent Profit Watchlists - Newser
What makes NextCure Inc. stock price move sharplyJuly 2025 Movers & Weekly Breakout Opportunity Watchlist - thegnnews.com
Market reaction to NextCure Inc.’s recent newsWeekly Trade Recap & Risk Controlled Swing Alerts - Newser
NextCure Inc. Company Revenue and Profit Trends: A Deep DiveMarket Volume Report & Free Low Drawdown Momentum Trade Ideas - Newser
Traders Watching For Reversal Pattern in NextCure Inc.Wall Street Watch & Daily Stock Trend Reports - sundaytimes.kr
Fibonacci Support Holding Strong in NextCure Inc.Index Update & Low Risk Investment Opportunities - kangso.co.kr
How to monitor NextCure Inc. with trend dashboardsJuly 2025 PreEarnings & Real-Time Price Movement Reports - Newser
Is it time to cut losses on NextCure Inc.Trade Volume Report & Weekly Market Pulse Updates - Newser
Backtesting results for NextCure Inc. trading strategiesShare Buyback & Stock Portfolio Risk Management - Newser
NextCure Inc. stock prediction for this weekWeekly Investment Recap & Weekly Breakout Stock Alerts - Newser
Using fundamentals and technicals on NextCure Inc.Market Performance Summary & Consistent Profit Focused Trading Strategies - Newser
Technical signs of recovery in NextCure Inc. [Rate Hike]Free Safe Investment Capital Preservation Plans - Newser
Technical signs of recovery in NextCure Inc.Technical Setup and Return Forecast Engine - Newser
NextCure Inc. stock volume spike explained2025 Growth vs Value & Risk Managed Investment Entry Signals - Newser
Published on: 2025-08-11 00:58:31 - Newser
Analysts Offer Insights on Healthcare Companies: Avalo Therapeutics (AVTX), Iovance Biotherapeutics (IOVA) and NextCure (NXTC) - The Globe and Mail
NextCure Reports Q2 2025 Earnings, Partners with Simcere Zaiming, and Advances Clinical Trials - AInvest
NextCure (NXTC) Q2 Loss Widens 71% - AOL.com
NextCure Reports Q2 2025 Results and Strategic Updates - TipRanks
NextCure Inc reports results for the quarter ended June 30Earnings Summary - TradingView
NextCure (NXTC) Q2 Loss Widens 71% - The Motley Fool
NextCure Provides Business Update and Reports Second Quarter 2025 Financial Results - The Manila Times
NextCure's Dual ADC Cancer Programs Progress: Strategic Partnership Fuels Clinical Advancement - Stock Titan
Short interest data insights for NextCure Inc.Long-Term Investment Strategy Impact Analysis - Newser
Finanzdaten der Nextcure Inc-Aktie (NXTC)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.41%
0.88%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):